SecBot SecBot
3 ·Filed Oct 23, 2026

HELP

Helus Pharma Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed2d 23h ago SEC0000912282-26-001380
Form 3 — initial insider ownership statement
Actionable Insight • Neutral

This is a routine initial ownership filing with no trading signal. Monitor future Form 4 filings for any open-market purchases or sales by Lawson, which would provide a clearer directional signal.

DirectionNeutral
Confidencehigh
Horizonimmediate

Price Chart

Loading chart...

Executive Summary

Mark Lawson filed a Form 3 initial statement of beneficial ownership, reporting 3,026 common shares held directly and 157,000 common shares held indirectly via Four Paths Partners Ltd. This is a routine insider filing with no trading activity or material financial information.

Key Facts

  • Mark Lawson filed Form 3 as a new reporting insider of Helus Pharma Inc.
  • Direct holdings: 3,026 common shares.
  • Indirect holdings: 157,000 common shares held through Four Paths Partners Ltd., a corporation owned and controlled by Lawson.
  • No open-market purchases or sales are reported; this is an initial ownership statement.

Financial Impact

No financial impact; the filing discloses existing ownership, not a transaction.

Risk Factors

  • No material risks identified from this filing.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
86% bullish (7 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
3 Filing (Primary)0000912282-26-001380
Document: 0000912282-26-001380-index.html0000912282-26-001380
Document: 0000912282-26-001380.txt0000912282-26-001380
36 reports for HELP
Performance horizon
50% Hit rate @ T+20 2 of 4 directional calls Went positive at some point 2 of 4 best @ T+20▲ +45.91%Aug 3, 2026
Filters
Rows
Reports for HELP — sortable, filterable
TypeNow
Oct 26, 2026
today
3
NEUTRAL ★ 2/10
$10.11awaiting T+20—$10.36 (+2.47%)
Oct 26, 2026
today
3
NEUTRAL ★ 2/10
$10.86awaiting T+20—$10.36 (−4.56%)
Oct 23, 2026
2d ago
3
NEUTRAL ★ 2/10
$10.50awaiting T+20—$10.36 (−1.33%)
Oct 23, 2026
2d ago
3
NEUTRAL ★ 2/10
$10.50awaiting T+20—$10.36 (−1.33%)
Oct 23, 2026
2d ago
3
NEUTRAL ★ 2/10
$10.50awaiting T+20—$10.36 (−1.33%)
Oct 23, 2026
2d ago
3
NEUTRAL ★ 2/10
$10.50awaiting T+20—$10.36 (−1.33%)
Oct 21, 2026
5d ago
6-K
NEUTRAL ★ 5/10
$10.50awaiting T+20—$10.36 (−1.33%)
Oct 15, 2026
11d ago
6-K
NEUTRAL ★ 3/10
$11.05awaiting T+20—$10.36 (−6.24%)
Oct 15, 2026
11d ago
Press Release
NEUTRAL ★ 3/10
$11.05awaiting T+20—$10.36 (−6.24%)
Oct 8, 2026
18d ago
6-K
NEUTRAL ★ 4/10
$10.72awaiting T+20—$10.36 (−3.36%)
Showing 10 of 36

US Market Status

Market Closed — Opens Tue (< 1m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 23, 2026